Pharming Group N.V. (AMS:PHARM)
Netherlands
· Delayed Price · Currency is EUR 0.7490
+0.0410 (5.79%)
Apr 8, 2025, 5:38 PM CET
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -11.84 | -10.55 | 13.67 | 16 | 37.75 | Upgrade
|
| Depreciation & Amortization | 10.19 | 10.13 | 9.33 | 9.17 | 8.31 | Upgrade
|
| Other Amortization | 0.85 | 0.88 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -21.28 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.03 | 4.92 | 3.86 | 10.44 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.99 | 0.93 | -11.06 | -0.11 | -0.07 | Upgrade
|
| Loss (Gain) on Equity Investments | 1.76 | 0.29 | 1.08 | -0.69 | -0.36 | Upgrade
|
| Stock-Based Compensation | 11.25 | 9.25 | 6.39 | 9.06 | 6.54 | Upgrade
|
| Other Operating Activities | -3.97 | 5.09 | -0.44 | -1.05 | 35.38 | Upgrade
|
| Change in Accounts Receivable | -6.78 | -18.54 | 2.36 | 5.92 | -7.04 | Upgrade
|
| Change in Inventory | -0.5 | -14.43 | -15.02 | -6.15 | -4.93 | Upgrade
|
| Change in Accounts Payable | -2.77 | 16.23 | 11.99 | -5.19 | 7.02 | Upgrade
|
| Change in Other Net Operating Assets | -0.02 | -0.22 | 0.27 | 0.47 | 1.04 | Upgrade
|
| Operating Cash Flow | -1.8 | -17.3 | 22.46 | 37.84 | 83.63 | Upgrade
|
| Operating Cash Flow Growth | - | - | -40.65% | -54.75% | 12.78% | Upgrade
|
| Capital Expenditures | -0.79 | -1.44 | -1.38 | -10.74 | -4.66 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.01 | 21.25 | -0.6 | -5.98 | -10.64 | Upgrade
|
| Investment in Securities | 32.41 | -149.2 | 7.3 | -4.59 | -0.33 | Upgrade
|
| Investing Cash Flow | 31.62 | -129.39 | 5.32 | -21.31 | -15.63 | Upgrade
|
| Long-Term Debt Issued | 104.54 | - | - | - | 142.83 | Upgrade
|
| Long-Term Debt Repaid | -138.93 | -4.04 | -3.31 | -3.22 | -59.42 | Upgrade
|
| Net Debt Issued (Repaid) | -34.39 | -4.04 | -3.31 | -3.22 | 83.41 | Upgrade
|
| Issuance of Common Stock | 5.58 | 8.13 | 2.28 | 4.72 | 2.79 | Upgrade
|
| Other Financing Activities | -5.6 | -5.13 | -3.95 | -29.45 | -25.51 | Upgrade
|
| Financing Cash Flow | -34.41 | -1.04 | -4.98 | -27.95 | 60.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.21 | 2.13 | -7.38 | -1.83 | 2.13 | Upgrade
|
| Net Cash Flow | -6.8 | -145.6 | 15.42 | -13.24 | 130.81 | Upgrade
|
| Free Cash Flow | -2.59 | -18.74 | 21.08 | 27.1 | 78.97 | Upgrade
|
| Free Cash Flow Growth | - | - | -22.21% | -65.68% | 10.44% | Upgrade
|
| Free Cash Flow Margin | -0.87% | -7.64% | 10.25% | 13.63% | 37.22% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.03 | 0.03 | 0.04 | 0.12 | Upgrade
|
| Cash Interest Paid | 5.6 | 5.13 | 3.95 | 4.45 | 2.14 | Upgrade
|
| Cash Income Tax Paid | 15.58 | 0.66 | 1.24 | - | 2.66 | Upgrade
|
| Levered Free Cash Flow | 0.24 | 8.06 | 16.23 | -17.14 | 44.3 | Upgrade
|
| Unlevered Free Cash Flow | 5.7 | 11.78 | 19.58 | -13.33 | 48.01 | Upgrade
|
| Change in Net Working Capital | 13.55 | 14.7 | 0.65 | 29.84 | 1.07 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.